Centre for Biomechanics and Rehabiliation Technologies, Staffordshire University, Stoke-on-Trent, UK.
Centre for Biomechanics and Rehabiliation Technologies, Staffordshire University, Stoke-on-Trent, UK
BMJ Open. 2021 Aug 9;11(8):e051381. doi: 10.1136/bmjopen-2021-051381.
This study aimed to achieve an expert consensus on how to define and group footwear interventions for children, with a further focus on the design characteristics and prescription of off-the-shelf stability footwear for children with mobility impairment.
A group of multinational professionals, from clinicians to those involved in the footwear industry, were recruited to ensure a spectrum of opinions.
Thirty panellists were contacted, of which 24 consented to participate and six withdrew before round 1, a further two withdrew after round 1. Sixteen panellists completed the consensus exercise.
A Delphi consensus method was employed with round 1 split into three sections: (1) terms and definitions, (2) specifics of off-the-shelf stability footwear design and (3) criteria for clinical prescription of off-the-shelf stability footwear. The panel was asked to rate their level of agreement with statements and to provide further insights through open-ended questions. The opinions of the experts were analysed to assess consensus set at 75% agreement or to modify or form new statements presented through the subsequent two rounds.
Therapeutic footwear was the agreed term to represent children's footwear interventions, with grouping and subgrouping of therapeutic footwear being dependent on their intended clinical outcomes (accommodative, corrective or functional). Both the heel counter and topline as well as the stiffness and width of the sole were identified as potentially influencing mediolateral stability in children's gait. A consensus was achieved in the prescription criteria and outcome measures for off-the-shelf stability therapeutic footwear for cerebral palsy, mobile symptomatic pes planus, Duchenne muscular dystrophy, spina bifida and Down's syndrome.
Through a structured synthesis of expert opinion, this study has established a standardisation of terminology and groupings along with prescription criteria for the first time. Reported findings have implications for communication between stakeholders, evidence-based clinical intervention and standardised outcome measures to assess effectiveness.
本研究旨在就如何定义和分类儿童用鞋具干预措施达成专家共识,重点进一步关注为行动障碍儿童设计和开具现成稳定性鞋具的特征和处方。
从临床医生到鞋具行业相关人员,我们招募了一组多国专业人员,以确保意见的多样性。
联系了 30 名专家组成员,其中 24 名同意参加,6 名在第一轮前退出,另有 2 名在第一轮后退出。16 名专家完成了共识研究。
采用德尔菲共识方法,第一轮分为三部分:(1)术语和定义,(2)现成稳定性鞋具设计细节,(3)现成稳定性鞋具临床处方标准。要求专家组对陈述的同意程度进行评分,并通过开放式问题提供进一步的见解。通过随后两轮,分析专家意见以评估 75%的一致性设定,修改或形成新的陈述。
治疗性鞋具是代表儿童鞋具干预措施的约定术语,治疗性鞋具的分组和分组取决于其预期的临床结果(适应性、矫正性或功能性)。后跟和鞋帮以及鞋底的刚度和宽度都被认为可能影响儿童步态的横向稳定性。在为脑瘫、移动性症状性平足、杜氏肌营养不良症、脊柱裂和唐氏综合征开具现成稳定性治疗性鞋具的处方标准和结果测量方面达成了共识。
通过专家意见的系统综合,本研究首次确立了术语和分组的标准化以及处方标准。报告的发现对利益相关者之间的沟通、基于证据的临床干预和评估有效性的标准化结果测量具有重要意义。